Literature DB >> 20307994

Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.

R L Puckett1, F Lorey, P Rinaldo, M H Lipson, D Matern, M E Sowa, S Levine, R Chang, R Y Wang, J E Abdenur.   

Abstract

Newborn screening (NBS) by tandem mass spectrometry (MS/MS) has allowed for early detection and initiation of treatment in many patients with maple syrup urine disease (MSUD) (OMIM 248600), however, a recent report suggests that variants forms may be missed. Information on these patients is limited. We present clinical, biochemical and molecular information on patients with variant forms of MSUD not detected by the California Newborn Screening Program. Between July 2005 and July 2009, 2200,000 newborns were screened in California by MS/MS. Seventeen cases of MSUD were detected and three (two siblings) were missed. Additionally, the NBS cards of two siblings with late onset MSUD, who were born pre-expanded NBS, were retrospectively analyzed. None of the five patients met criteria to be considered presumptive positive for MSUD (leucine>200micromol/L and a ratio of leucine/alanine>or=1.5). Alloisoleucine (allo-ile) was subsequently analyzed in the NBS cards of all five patients, two of whom were found to have elevated levels. The proband in each family was diagnosed following symptoms triggered by an intercurrent illness or increased protein intake. At diagnosis, leucine levels ranged between 561 and >4528micromol/L, and allo-ile ranged from 137 to 239micromol/L. Two affected siblings had normal plasma amino acids when asymptomatic; however, their biochemical profiles were diagnostic of MSUD during intercurrent illnesses. The median age at diagnosis of all patients was one year (range 0.8-6.7). Heterozygous BCKDHB (E1beta) mutations (c.832G>A/c.970C>T) were identified in one family and a homozygous DBT (E2) sequence variant (c.1430 T>G) in another. The third family had one identifiable DBT mutation (c.827T>G), however, a second mutation was not detected. This report provides further evidence that NBS by MS/MS is unable to detect all cases of MSUD. Second-tier testing with allo-ile may improve sensitivity; however, some children with variant forms will invariably be missed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20307994     DOI: 10.1016/j.ymgme.2009.11.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

Review 1.  Genetic screening.

Authors:  Wylie Burke; Beth Tarini; Nancy A Press; James P Evans
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

2.  Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation.

Authors:  Johannes A Mayr; Franz A Zimmermann; Christine Fauth; Christa Bergheim; David Meierhofer; Doris Radmayr; Johannes Zschocke; Johannes Koch; Wolfgang Sperl
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

3.  Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses.

Authors:  Trine Tangeraas; Ingjerd Sæves; Claus Klingenberg; Jens Jørgensen; Erle Kristensen; Gunnþórunn Gunnarsdottir; Eirik Vangsøy Hansen; Janne Strand; Emma Lundman; Sacha Ferdinandusse; Cathrin Lytomt Salvador; Berit Woldseth; Yngve T Bliksrud; Carlos Sagredo; Øyvind E Olsen; Mona C Berge; Anette Kjoshagen Trømborg; Anders Ziegler; Jin Hui Zhang; Linda Karlsen Sørgjerd; Mari Ytre-Arne; Silje Hogner; Siv M Løvoll; Mette R Kløvstad Olavsen; Dionne Navarrete; Hege J Gaup; Rina Lilje; Rolf H Zetterström; Asbjørg Stray-Pedersen; Terje Rootwelt; Piero Rinaldo; Alexander D Rowe; Rolf D Pettersen
Journal:  Int J Neonatal Screen       Date:  2020-06-27

4.  Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features.

Authors:  Mary Anne D Chiong; Marilyn A Tan; Cynthia P Cordero; Esphie Grace D Fodra; Judy S Manliguis; Cristine P Lopez; Leslie Michelle M Dalmacio
Journal:  Mol Genet Metab Rep       Date:  2016-10-12

5.  Newborn screening for dihydrolipoamide dehydrogenase deficiency: Citrulline as a useful analyte.

Authors:  Shane C Quinonez; Andrea H Seeley; Mary Seeterlin; Eleanor Stanley; Ayesha Ahmad
Journal:  Mol Genet Metab Rep       Date:  2014-08-15

Review 6.  Maple syrup urine disease: mechanisms and management.

Authors:  Patrick R Blackburn; Jennifer M Gass; Filippo Pinto E Vairo; Kristen M Farnham; Herjot K Atwal; Sarah Macklin; Eric W Klee; Paldeep S Atwal
Journal:  Appl Clin Genet       Date:  2017-09-06

7.  Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California.

Authors:  Hao Tang; Lisa Feuchtbaum; Partha Neogi; Thomson Ho; Leslie Gaffney; Robert J Currier
Journal:  Genet Med       Date:  2015-12-10       Impact factor: 8.822

8.  Rapid quantification of underivatized amino acids in plasma by hydrophilic interaction liquid chromatography (HILIC) coupled with tandem mass-spectrometry.

Authors:  Hubertus C M T Prinsen; B G M Schiebergen-Bronkhorst; M W Roeleveld; J J M Jans; M G M de Sain-van der Velden; G Visser; P M van Hasselt; N M Verhoeven-Duif
Journal:  J Inherit Metab Dis       Date:  2016-04-21       Impact factor: 4.982

9.  Disorders of branched chain amino acid metabolism.

Authors:  I Manoli; C P Venditti
Journal:  Transl Sci Rare Dis       Date:  2016-11-07

10.  Recurrent Encephalopathy During Febrile Illnesses in a 6-Year-Old Boy.

Authors:  Eliza Szuch; Jeanna Auriemma
Journal:  Glob Pediatr Health       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.